cimb-logo

Journal Browser

Journal Browser

Molecular Approaches in Early Detection and Targeted Therapies for Pancreatic Cancer

A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 20 August 2026 | Viewed by 513

Special Issue Editor


E-Mail Website
Guest Editor
Department of Surgery, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63115, USA
Interests: cancer; inflammation; immunology; RNA biology; molecular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Pancreatic cancer remains one of the most lethal malignancies, with an overall five-year survival rate of approximately 11% and projected to become the second leading cause of cancer death by 2030. Late diagnosis, with only 10-15% of patients presenting with resectable disease, emphasizes the urgent need for innovative molecular detection strategies across all pancreatic cancer subtypes.

Molecular approaches have shown great promise in addressing these challenges. Recent advances in multi-omics technologies, understanding of tumor–stroma interactions, and tumor immune microenvironment are enabling the discovery of novel biomarkers for early diagnosis, elucidating key oncogenic pathways, and facilitating the development of targeted therapies that disrupt specific oncogenic pathways and tumor microenvironment components.

This Special Issue welcomes original research and comprehensive reviews focusing on molecular strategies for the early detection and personalized treatment of pancreatic cancer. Priority areas include novel biomarker discovery, liquid biopsy applications, mechanistic studies of tumor biology, targeted therapeutic development, and the clinical translation of molecular diagnostics. We seek contributions that advance our understanding of pancreatic cancer molecular pathogenesis and accelerate the development of clinically meaningful diagnostic and therapeutic innovations.

Dr. Hassan Mubarak Ishqi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pancreatic cancer
  • early detection
  • molecular biomarkers
  • targeted therapy
  • genomics
  • tumor microenvironment
  • precision medicine
  • transcriptomics
  • proteomics
  • cancer diagnostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

20 pages, 897 KB  
Review
Molecular Subtypes of Pancreatic Cancer: A Review of the Literature
by Jakub Wnuk, Wiktoria Skowron, Anna Długaszek, Joanna Sadurska, Łukasz Pietrzyński, Jacek Kabut and Iwona Gisterek-Grocholska
Curr. Issues Mol. Biol. 2026, 48(5), 502; https://doi.org/10.3390/cimb48050502 - 13 May 2026
Viewed by 199
Abstract
Pancreatic cancer (PC) is considered one of the deadliest cancers worldwide, and the number of PC-related deaths is expected to increase. Early diagnosis of PC is crucial for improving treatment outcomes. Despite improvements in overall survival (OS) in metastatic and unresectable PC due [...] Read more.
Pancreatic cancer (PC) is considered one of the deadliest cancers worldwide, and the number of PC-related deaths is expected to increase. Early diagnosis of PC is crucial for improving treatment outcomes. Despite improvements in overall survival (OS) in metastatic and unresectable PC due to systemic therapy, there is still a need to search for novel therapies and factors predictive of response to treatment. Cancer profiling based on genome sequencing can be used to develop targeted therapies and improve prognostics and treatment outcomes. Therefore, this review was conducted to evaluate the clinical value of molecular subtyping in pancreatic cancer as a prognostic and predictive factor in pancreatic cancer. Due to its limitations, including the lack of a registered protocol and risk of bias assessment for the included studies and those whose results were not included, this study should be considered a narrative review with a structured search strategy rather than a systematic review. Full article
Show Figures

Figure 1

Back to TopTop